Amrutanjan Health Care Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025. The Board of Directors, in their meeting held on February 3, 2026, approved these results as recommended by the Audit Committee. The company reported a profit after tax of ₹1,945.22 Lakhs for the quarter, a significant increase from ₹1,396.16 Lakhs in the same period last year. For the nine-month period ended December 31, 2025, the profit after tax stood at ₹4,172.50 Lakhs, up from ₹3,565.69 Lakhs in the corresponding period of the previous year. The Board also declared a second interim dividend of ₹1 per equity share for the financial year 2025-26. Additionally, the company noted its ESG rating of 68.6 from SES ESG Research Private Limited. The Board meeting commenced at 12:45 P.M. and concluded at 5:00 P.M. on February 3, 2026.
